Spine Biologics Market Trends, Analysis, Overview, Development, 2017 And Forecast To 2024

Global Spine Biologics Market By Product (Bone Allografts, Bone Graft Substitute, Platelet Rich Plasma, Bone Marrow Aspirate Therapy), By End-User (Hospitals, Spinal Surgery Centers, Orthopedic Clinics, Others), By Geography (North America, Europe, Asia-Pacific, South America, Rest of the World) – Trends and Forecast to 2024

The global spine biologics market is expected to reach USD 2.7 billion by 2024 at a CAGR of 4.4% from 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.


Biologics assist the natural process of bone formation. They can also be used as products that can cure the diseaseor degenerated discs. Biologics for spine includes all the biological materials that play a role in a spinal procedure;these are one of the most innovative advances in spine surgical treatment. These are implants used in lieuallografts or as a support for bones in and around the spinal region.

Some of the major Companies operating in the global spine biologics market are:

·         Arthrex, Inc.
·         Cesca Therapeutics, Inc.
·         DepuySynthes, Inc.
·         DMP Spine
·         Exactech, Inc.
·         K2m, Inc.
·         Lattice Biologics
·         Medtronic
·         Nuo Therapeutics, Inc.
·         Nutech
·         Nuvasive, Inc.
·         Orthofix Holdings, Inc.
·         Regen Lab Sa
·         RTI Surgical, Inc.
·         Stryker Corporation
·         Wright Medical Technology, Inc.
·         X-Spine Systems, Inc.
·         Zimmer Holdings, Inc.


The Global Spine Biologics market is segmented on the basis of product type, surgery type and geography.

On the basis of product type the spine biologics market is segmented into bone grafts; bone graft substitutes; platelet-rich plasma (PRP) and bone marrow aspirate therapy among others.

Based on surgery type, the market is segmented into Anterior Cervical Discectomy and Fusion (ACDF); Transforamenal Lumbar Interbody Fusion (TLIF); Anterior Lumbar Interbody Fusion (ALIF); Lateral Lumbar Interbody Fusion (LLIF) among others.

On the basis of end-users the market is segmented into Hospitals, Spinal Surgery Centers, Orthopedic Clinics, Others.

Based on geography the Global Spine Biologics Market is segmented into geographical regions such as North America, Europe, South America, Asia-Pacific, and Rest of the World (RoW).
The Global Spine Biologics market is highly competitive and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes company share analysis for the major companies operating in this market by major regions North America, Europe and Asia Pacific.


Table of Content:

1. INTRODUCTION
       1.1. OVERVIEW OF THE SPINE BIOLOGICS MARKET
       1.2. MARKET SEGMENTATION & COVERAGE
                1.2.1. CURRENCY AND PRICING
                1.2.2. LIMITATION
                1.2.3. STAKEHOLDERS
2. RESEARCH METHODOLOGY
       2.1. KEY TAKEAWAYS
       2.2. ARRIVING AT THE GLOBAL SPINE BIOLOGICS MARKET SIZE
       2.3. GLOBAL SPINE BIOLOGICS MARKET: RESEARCH SNAPSHOT
       2.4. ASSUMPTIONS
3. MARKET LANDSCAPE SUMMARY
4. PREMIUM INSIGHTS
       4.1. OVERVIEW
       4.2. GLOBAL SPINE BIOLOGICS MARKET: KEY PRIMARY INSIGHTS
       4.3. MARKET OVERVIEW
       4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES
5. SPINE BIOLOGICS MARKET, BY PRODUCT TYPE
       5.1. OVERVIEW
       5.2. BONE GROWTH SUBSTITUTES
       5.3. BONE ALLOGRAFTS
       5.4. PLATELET RICH PLASMA (PRP)
       5.5. BONE MARROW ASPIRATE CONCENTRATE (BMAC
6. SPINE BIOLOGICS MARKET, BY SURGERY TYPE
       6.1. OVERVIEW
       6.2. ANTERIOR CERVICAL DISECTOMY AND FUSION (ACDF)
       6.3. TRANSFORAMENAL LUMBAR INTERBODY FUSION (TLIF)
       6.4. ANTERIOR LUMBAR INTERBODY FUSION (ALIF)
       6.5. LATERAL LUMBAR INTERBODY FUSION (LLIF)
       6.6. OTHERS
7. SPINE BIOLOGICS MARKET, BY END USER
       7.1. OVERVIEW
       7.2. HOSPITALS
       7.3. SPINAL SURGERY CENTERS
       7.4. ORTHOPEDIC CLINICS
       7.5. OTHERS
8. SPINE BIOLOGICS MARKET, BY GEOGRAPHY
       8.1. COUNTRYWISE SPINE BIOLOGICS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
                8.1.1. NORTH AMERICA
                8.1.2. EUROPE
                8.1.3. ASIA-PACIFIC (APAC)
                8.1.4. LATIN AMERICA
                8.1.5. MIDDLE EAST AND AFRICA
       8.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
9. SPINE BIOLOGICS MARKET: COMPETITIVE LANDSCAPE
       9.1. GLOBAL SPINE BIOLOGICS MARKET: COMPANY SHARE ANALYSIS
       9.2. U.S. SPINE BIOLOGICS MARKET: COMPANY SHARE ANALYSIS
       9.3. EUROPE SPINE BIOLOGICS MARKET: COMPANY SHARE ANALYSIS
       9.4. APAC SPINE BIOLOGICS MARKET: COMPANY SHARE ANALYSIS
       9.5. SOUTH AMERICA SPINE BIOLOGICS MARKET: COMPANY SHARE ANALYSIS
       9.6. MIDDLE EAST AND AFRICA  SPINE BIOLOGICS MARKET: COMPANY SHARE ANALYSIS
       9.7. MERGERS & ACQUISITIONS
       9.8. NEW PRODUCT DEVELOPMENT & APPROVALS
       9.9. EXPANSIONS
       9.10. REGULATORY CHANGES
       9.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
10. SPINE BIOLOGICS MARKET, COMPANY PROFILES
       10.1. APPLIED BIOLOGICS
       10.2. ARTHREX, INC.
       10.3. CESCA THERAPEUTICS
       10.4. DEPUY SYNTHES
       10.5. DMP SPINE
       10.6. DR. PRP AMERICA LLC.
       10.7. EXACTECH, INC.
       10.8. K2M, INC.
       10.9. LATTICE BIOLOGICS
       10.10. MEDTRONIC
       10.11. NUVASIVE, INC.
       10.12. ORTHOFIX HOLDINGS, INC.
       10.13. REGENLAB S.A.
       10.14. RTI SURGICAL
       10.15. STRYKER CORPORATION
       10.16. WRIGHT MEDICAL
       10.17. X-SPINE SYSTEMS
       10.18. ZIMMER BIOMET

Related Report

Global Tumour Ablation Market – Trends and Forecast to 2024

Global Tumour Ablation Market, By Type (Tumour Ablation Systems (Radio Frequency Ablation, Microwave Ablation, HIFU, Laser Ablation, Cryoablation), Image Guidance Products, Accessories), By Cancer Type (Liver, Lings, Kidney, Brain, Bone, Pancreas, Breast, Others), By End-User (Hospitals, Oncology Clinics, Others), By Geography (North America, South America, Europe, Asia-Pacific, Rest of the World) – Trends and Forecast to 2024

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Ankit Singh
Data Bridge Market Research
Tel: +1-888-387-2818
Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research

Share this

Related Posts

Previous
Next Post »

Blog Archive

Powered by Blogger.